Tradestie Institutional Equity Comparison Engine

CAPR vs EYPT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CAPR Overall Edge

CAPR Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Capricor Therapeutics Inc (CAPR) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while EYPT counters with relative strength in Valuation. Fundamentally, CAPR trades at 78.7x Forward P/E with 0.0% operating margin (-7.9% YoY revenue) versus EYPT at 6.2x Forward P/E and -11369.3% operating margin (-90.5% YoY). In options structure, CAPR sits in CONSOLIDATION (89th %ile IV; Dealer Gamma Walls on Pro) against EYPT sits in BREAKDOWN (47th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner EYPT
CAPR 78.7x vs EYPT 6.2x Fwd P/E
Growth & Margin Winner CAPR
Op Margin 0.0% vs -11369.3% ยท YoY -7.9% vs -90.5%
Momentum & Technical Winner CAPR
1Y +44.3% vs -97.4% ยท 52W Pos 15% vs 0%
Options & Structure Winner CAPR
CONSOLIDATION (89th %ile IV) vs BREAKDOWN (47th %ile IV)
CAPR NASDAQ
Capricor Therapeutics Inc
Pharmaceutical Preparations
$8.47
-11.12% 1D
Market Cap $595.4M
1M Return +26.23%
1Y Return +44.29%
Forward P/E 78.7x
Unified AI Score
28.0 / 100 SELL
Tech 50.0 Fund 37.0 Flow 68.0 Mom 50.0
EYPT NASDAQ
EyePoint Pharmaceuticals, Inc. Common Stock
Laboratory Analytical Instruments
$0.30
-3.14% 1D
Market Cap $26.8M
1M Return -90.09%
1Y Return -97.42%
Forward P/E 6.2x
Unified AI Score
43.5 / 100 HOLD
Tech 35.0 Fund 49.0 Flow 72.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CAPR +44.29% EYPT -97.42% Spread: +144.21 pp (CAPR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CAPR Revenue EYPT Revenue CAPR Op. Margin EYPT Op. Margin Margin Edge
FY2018 $0M $0M -917.0% -853.6% EYPT
FY2019 $0M $20M -769.5% -235.0% EYPT
FY2020 $0M $30M -4412.6% -108.3% EYPT
FY2021 $0M $40M -8549.9% -149.6% EYPT
FY2022 $0M $40M -1163.9% -240.6% EYPT
FY2023 $30M $50M -95.6% -163.1% CAPR
FY2024 $20M $40M -191.1% -337.1% CAPR
FY2025 N/A $30M N/A -776.0% EYPT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CAPR (5) vs EYPT (4)
Institutional Metric CAPR EYPT Criterion Row Winner
Market Capitalization Scale $595.4M $26.8M Larger Scale CAPR
Trailing P/E Ratio Valuation 78.7x 6.2x Lower Multiple EYPT
Forward P/E Ratio Valuation 78.7x 6.2x Lower Multiple EYPT
Revenue Growth (YoY) Growth -7.9% -90.5% Higher Growth CAPR
Operating Margin (TTM) Profitability 0.0% -11369.3% Higher Margin CAPR
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -100.5% -148.7% Higher ROE CAPR
52-Week Range Position Momentum 15% ($3โ€“$40) 0% ($0โ€“$19) Stronger Trend CAPR
Beta / 30D Volatility Risk Regime 1.52ฮฒ ยท 152% Vol 1.43ฮฒ ยท 104% Vol Lower Realized Risk EYPT
Unified Institutional Score Composite Signal 28.0 / 100 (SELL) 43.5 / 100 (HOLD) Higher Composite EYPT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CAPR vs EYPT Buy Guide
CAPR CONSOLIDATION
56d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 89th %ile
IV Regime Extreme (>80th %ile)
Live CAPR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EYPT BREAKDOWN
89d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 47th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EYPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CAPR nor EYPT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.